New study unlocks clues to preventing low blood sugar in diabetes
NCT ID NCT06881472
First seen Oct 01, 2025 · Last updated May 12, 2026 · Updated 22 times
Summary
This study looked at how two natural substances—GIP (a gut hormone) and alanine (an amino acid from protein)—affect glucagon release in people with and without type 1 diabetes. Glucagon helps raise blood sugar when it drops too low, but people with type 1 diabetes often can't produce it properly. Ten participants were given GIP and alanine separately and together to measure their combined effect on glucagon. The goal is to better understand these interactions, which could lead to new ways to prevent dangerous low blood sugar in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Gentofte Hospital
Hellerup, 2900, Denmark
Conditions
Explore the condition pages connected to this study.